Michael S. Iskra - 01 Jun 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Jun 2024, 16:15:38 UTC
Prior SEC filing
01 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Michael S. Iskra

Key filing fact

Michael S. Iskra filed Form 4 for QuidelOrtho Corp (QDEL) on 04 Jun 2024.

Key facts

  • This page summarizes Michael S. Iskra's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Jun 2024, 16:15.

Change

  • Previous filing in this sequence was filed on 01 Apr 2024.
  • Current net transaction value: -$57,447.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+3,594
Change %
+25%
Price
$0.000000
Shares after
17,944
Date
01 Jun 2024
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
$57,447
Shares
-1,300
Change %
-7.2%
Price
$44.19
Shares after
16,644
Date
01 Jun 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,594
Change %
-50%
Price
$0.000000
Shares after
3,594
Date
01 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,594
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

Footnote F3

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F4

3,594 shares vested on June 1, 2024; the remaining 3,594 shares will vest on June 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .